Vitalief
Business Services · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
317 George St Ste 320, New Brunswick, Ne...Website
www.vitalief.comRevenue
<$5 MillionIndustry
About Vitalief
Vitalief is an innovative Site Management Organization (SMO) that operates at the intersection of Sponsors, CROs, and Sites to enhance the clinical research landscape. They provide consulting and Functional Service Provider (FSP) solutions that streamline operations, reduce costs, and expedite the development of new therapies for patients. Their services address challenges such as trial rescue, rapid trial activation, and financial operations optimization, while fostering collaboration among stakeholders. Vitalief serves a diverse range of clients, including pharmaceutical companies, medical device sponsors, academic institutions, and independent research sites.Explore more
Vitalief Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Vitalief
Compare insights from companies similar to Vitalief, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Vitalief Tech Stack
A closer look at the technologies used by Vitalief
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vitalief
Sign Up For FreeTo access detailed company insights
Vitalief is an innovative Site Management Organization (SMO) that operates at the intersection of Sponsors, CROs, and Sites to enhance the clinical research landscape. They provide consulting and Functional Service Provider (FSP) solutions that streamline operations, reduce costs, and expedite the development of new therapies for patients. Their se... Read More
